Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (11-20 of 418) with videos related to

Pageof 42
Sort By:
Lancet (London, England)|July 9, 2019
Interleukin-23 blockade: another breakthrough in the treatment of psoriasisMark Lebwohl
Annals of Internal Medicine|May 18, 2011
ACP journal club. Regular sunscreen use reduces invasive but not overall melanoma in white adultsMark Lebwohl
Photodermatology, Photoimmunology & Photomedicine|May 2, 2002
Should we switch from combination UVA/UVB phototherapy units to narrowband UVB?Mark Lebwohl
Journal of Drugs in Dermatology : JDD|January 5, 2013
JDD: celebrating 10 years of publishing excellenceMark Lebwohl
JAMA Dermatology|April 7, 2021
Biosimilars in DermatologyMark Lebwohl
The Journal of Clinical and Aesthetic Dermatology|January 5, 2011
What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers?Mark Lebwohl
Journal of the American Academy of Dermatology|February 16, 2018
Reply to: "Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials"Mark Lebwohl
Journal of the American Academy of Dermatology|July 10, 2004
Innovations in the treatment of psoriasisMark Lebwohl
The Journal of Investigative Dermatology|November 26, 2016
Psoriasis Therapy: Breakthroughs in Pharmacogenomics or in Pharmacology?Mark Lebwohl
The Journal of Investigative Dermatology|April 18, 2015
Biologics for psoriasis: a translational research success storyMark Lebwohl
Pageof 42

Showing results (11-20 of 418) with videos related to

Sort By:
Pageof 42
Lancet (London, England)|July 9, 2019
Interleukin-23 blockade: another breakthrough in the treatment of psoriasisMark Lebwohl
Annals of Internal Medicine|May 18, 2011
ACP journal club. Regular sunscreen use reduces invasive but not overall melanoma in white adultsMark Lebwohl
Photodermatology, Photoimmunology & Photomedicine|May 2, 2002
Should we switch from combination UVA/UVB phototherapy units to narrowband UVB?Mark Lebwohl
Journal of Drugs in Dermatology : JDD|January 5, 2013
JDD: celebrating 10 years of publishing excellenceMark Lebwohl
JAMA Dermatology|April 7, 2021
Biosimilars in DermatologyMark Lebwohl
The Journal of Clinical and Aesthetic Dermatology|January 5, 2011
What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers?Mark Lebwohl
Journal of the American Academy of Dermatology|February 16, 2018
Reply to: "Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials"Mark Lebwohl
Journal of the American Academy of Dermatology|July 10, 2004
Innovations in the treatment of psoriasisMark Lebwohl
The Journal of Investigative Dermatology|November 26, 2016
Psoriasis Therapy: Breakthroughs in Pharmacogenomics or in Pharmacology?Mark Lebwohl
The Journal of Investigative Dermatology|April 18, 2015
Biologics for psoriasis: a translational research success storyMark Lebwohl
Pageof 42